By Jonathan Stempel (Reuters) – A Virginia doctor who prescribed more than 500,000 opioid doses in less than two years…
Read More »DOSES
juststock NKGen Biotech (NASDAQ:NKGN) said it has dosed its first patient in a Phase 1/2a study of its cell therapy…
Read More »